Objectives
After participating in this educational activity, attendees should be able to:
1|Review the basic pharmacology use of sugammadex, rocuronium, and vecuronium, their therapeutic uses, mechanisms of action, and potential risks to patient associated with each agent.
2|Explain pharmacology interactions and patient safety considerations when using rocuronium and vecuronium in combination.
3|Discuss storage of recuronium and differences in temperature, and analyze the implications of improper storage on drug efficacy and patient safety.
4|Discuss reversal and train of 4s basics.
Presenter(s):
Connie Chen, D.O.
Anesthesia Resident
Department of Anesthesiology
University of Massachusetts Chan Medical School
Baystate Medical Center
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Connie Chen, D.O. | Speaker/Author | No relevant relationships with ineligible companies to disclose | Not Applicable |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Risk Management
Facebook
X
LinkedIn
Forward